Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cooper Companies Inc (NYSE:COO)

232.53
BATS BZX Real-Time Price
As of 11:50am ET
 +0.12 / +0.05%
Today’s Change
158.73
Today|||52-Week Range
256.39
+32.93%
Year-to-Date
4 Momentum Stocks to Pick Despite MedTech Policy Debacle
Sep 15 / Zacks.com - Paid Partner Content
Cooper Companies Buys Teva's PARAGARD Intrauterine Platform
Sep 12 / Zacks.com - Paid Partner Content
Teva's Leukemia Drug sNDA Granted Priority Review by the FDA
Sep 13 / Zacks.com - Paid Partner Content
Top Ranked Momentum Stocks to Buy for September 8th
Sep 08 / Zacks.com - Paid Partner Content
Dental Faces Regulatory Challenges: Only 5 Stocks to Pick
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close232.41
Today’s open232.61
Day’s range230.97 - 232.62
Volume10,931
Average volume (3 months)455,476
Market cap$11.4B
Dividend yield0.03%
Data as of 11:50am ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+35.02%
Earnings growth (this year)+15.11%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+9.45%
P/E ratio33.3
Price/Sales4.39
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
GKOSGlaukos Corp-0.48-1.49%
STAASTAAR Surgical Co+0.15+1.38%
Data as of 11:35am ET, 09/22/2017

Financials

Next reporting dateDecember 7, 2017
EPS forecast (this quarter)$2.66
Annual revenue (last year)$2.0B
Annual profit (last year)$273.9M
Net profit margin13.93%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO &
Non-Independent Director
Robert S. Weiss
Chief Operating Officer &
Executive Vice President
Daniel G. McBride
Corporate headquarters
Pleasanton, California

Forecasts